Clinical Trial Update: Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation [Phase 3]

View source ↗

Summary

Phase 3 pharmacodynamic, pharmacokinetic, and tolerability study of a liquid form of lubiprostone in adults with chronic idiopathic constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Constipation

Drugs mentioned

• LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Mallinckrodt | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: COMPLETED | Results posted: 2019-12-13